GP
SGYP

GLG Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

GLG Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-185,631
Closed -$984K – 552
2015
Q3 		$984K Buy
+185,631
New +$1.44M 0.03% 359

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GLG Partners's SGYP Position: Q4 2015 in Review

GLG Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2015, closing a stake of 185,631 shares — an estimated $984K sold.

GLG Partners first reported a position in SGYP in Q3 2015 and held it in 1 quarter. The position peaked at $984K in Q3 2015. 127 funds tracked by Wall St. Rank hold SGYP as of Q4 2015.

  • GLG Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2015 after selling out during the quarter.
  • GLG Partners sold 185,631 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2015, an estimated $984K.
  • GLG Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 1 quarter.
  • GLG Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $984K in Q3 2015.
  • 127 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2015.

Based on GLG Partners's 13F filing for Q4 2015, filed 16 Feb 2016.